Generation of High-Yielding Influenza A Viruses in African Green Monkey Kidney (Vero) Cells by Reverse Genetics

Journal of Virology

Volumn 78, Issue 4, 2004, Pages 1851-1857

  Ozaki, Hiroichi ^a   Govorkova, Elena A ^a   Li, Chenghong ^a   Xiong, Xiaoping ^a   Webster, Robert G ^a   Webby, Richard J ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BIRD; CERCOPITHECIDAE; CONTROLLED STUDY; INFLUENZA VIRUS A; KIDNEY CELL; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; VACCINE PRODUCTION; VERO CELL; VIRAL GENETICS; VIROGENESIS; VIRUS CULTURE; VIRUS STRAIN; ZOONOSIS;

ANIMALS; CERCOPITHECUS AETHIOPS; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; REASSORTANT VIRUSES; VERO CELLS; VIRAL NONSTRUCTURAL PROTEINS; VIRUS CULTIVATION; VIRUS REPLICATION;

EID: 0842326027     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.4.1851-1857.2004     Document Type: Article

References (49)

1. Bates, D. M., and D. Watts. 1988. Nonlinear regression analysis and its application. Wiley, New York, N.Y.
2. Bruhl, P., A. Kerschbaum, O. Kistner, N. Barrett, F. Dorner, and M. Gerencer. 2000. Humoral and cell-mediated immunity to vero cell-derived influenza vaccine. Vaccine 19:1149-1158.
3. Bullido, R., P. Gomez-Puertas, M. J. Saiz, and A. Portela. 2001. Influenza A virus NEP (NS2 protein) downregulates RNA synthesis of model template RNAs. J. Virol. 75:4912-4917.
4. Clements, M. L., E. K. Subbarao, L. F. Fries, R. A. Karron, W. T. London, and B. R. Murphy. 1992. Use of single-gene reassortant viruses to study the role of avian influenza A virus genes in attenuation of wild-type human influenza A virus for squirrel monkeys and adult human volunteers. J. Clin. Microbiol. 30:655-662.
5. Davidian, M., and D. M. Gilitinan. 1996. Nonlinear models for repeated measurement data. Chapman & Hall, New York, N.Y.
6. Diaz, M. O., S. Ziemin, M. M. Le Beau, P. Pitha, S. D. Smith, R. R. Chilcote, and J. D. Rowley. 1988. Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines. Proc. Natl. Acad. Sci. USA 85:5259-5263.
7. Fodor, E., L. Devenish, O. G. Engelhardt, P. Palese, G. G. Brownlee, and A. Garcia-Sastre. 1999. Rescue of influenza A virus from recombinant DNA. J. Virol. 73:9679-9682.
8. Fortes, P., A. Beloso, and J. Ortin. 1994. Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport. EMBO J. 13:704-712.
9. Garcia-Sastre, A., A. Egorov, D. Matassov, S. Brandt, D. E. Levy, J. E. Durbin, P. Palese, and T. Muster. 1998. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252:324-330.
10. Gerdil, C. 2003. The annual production cycle for influenza vaccine. Vaccine 21:1776-1779.
11. Govorkova, E. A., N. V. Kaverin, L. V. Gubareva, B. Meignier, and R. G. Webster. 1995. Replication of influenza A viruses in a green monkey kidney continuous cell line (Vero). J. Infect. Dis. 172:250-253.
12. Govorkova, E. A., G. Murti, B. Meignier, C. de Taisne, and R. G. Webster. 1996. African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses. J. Virol. 70:5519-5524.
13. Grassauer, A., A. Y. Egorov, B. Ferko, I. Romanova, H. Katinger, and T. Muster. 1998. A host restriction -based selection system for influenza haemagglutinin transfectant viruses. J. Gen. Virol. 79:1405-1409.
14. Hatta, M., P. Halfmann, K. Wells, and Y. Kawaoka. 2002. Human influenza a viral genes responsible for the restriction of its replication in duck intestine. Virology 295:250-255.
15. Hoffmann, E., S. Krauss, D. Perez, R. Webby, and R. Webster. 2002. Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine 20:3165-3170.
16. Hoffmann, E., G. Neumann, Y. Kawaoka, G. Hobom, and R. G. Webster. 2000. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. USA 97:6108-6113.
17. Hoffmann, E., J. Stech, Y. Guan, R. G. Webster, and D. R. Perez. 2001. Universal primer set for the full-length amplification of all influenza A viruses. Arch. Virol. 146:2275-2289.
18. Hoffmann, E., J. Stech, I. Leneva, S. Krauss, C. Scholtissek, P. S. Chin, M. Peiris, K. F. Shortridge, and R. G. Webster. 2000. Characterization of the influenza A virus gene pool in avian species in southern China: was H6N1 a derivative or a precursor of H5N1? J. Virol. 74:6309-6315.
19. Katz, J. M., C. W. Naeve, and R. G. Webster. 1987. Host cell-mediated variation in H3N2 influenza viruses. Virology 156:386-395.
20. Kaverin, N. V., and R. G. Webster. 1995. Impairment of multicycle influenza virus growth in Vero (W. H. O.) cells by loss of trypsin activity. J. Virol. 69:2700-2703.
21. Kemble, G., and H. Greenberg. 2003. Novel generations of influenza vaccines. Vaccine 21:1789-1795.
22. Kida, H., L. E. Brown, and R. G. Webster. 1982. Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A/Seal/Massachusetts/1/80 (H7N7) influenza virus. Virology 122:38-47.
23. Kistner, O., P. N. Barrett, W. Mundt, M. Reiter, S. Schober-Bendixen, G. Eder, and F. Dorner. 1999. Development of a Vero cell-derived influenza whole virus vaccine. Dev. Biol. Stand. 98:101-110.
24. Lau, S. C., and C. Scholtissek. 1995. Abortive infection of Vero cells by an influenza A virus (FPV). Virology 212:225-231.
25. Maassab, H. F., and D. C. DeBorde. 1983. Characterization of an influenza A host range mutant. Virology 130:342-350.
26. Montagnon, B. J., B. Fanget, and A. J. Nicolas. 1981. The large-scale cultivation of VERO cells in micro-carrier culture for virus vaccine production. Preliminary results for killed poliovirus vaccine. Dev. Biol. Stand. 47:55-64.
27. Monto, A. S., H. F. Maassab, and E. R. Bryan. 1981. Relative efficacy of embryonated eggs and cell culture for isolation of contemporary influenza viruses. J. Clin. Microbiol. 13:233-235.
28. Nakamura, K., and M. Homma. 1981. Protein synthesis in Vero cells abortively infected with influenza B virus. J. Gen. Virol. 56:199-202.
29. Nemeroff, M. E., S. M. Barabino, Y. Li, W. Keller, and R. M. Krug. 1998. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3′end formation of cellular pre-mRNAs. Mol. Cell 1:991-1000.
30. Neumann, G., T. Watanabe, H. Ito, S. Watanabe, H. Goto, P. Gao, M. Hughes, D. R. Perez, R. Donis, E. Hoffmann, G. Hobom, and Y. Kawaoka. 1999. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl. Acad. Sci. USA 96:9345-9350.
31. O'Connel, M. A., B. A. Belanger, and P. D. Haaland. 1993. Calibration and assay development using the four-parameter logistic model. Chemom. Intell. Lab. Syst. 20:97-114.
32. O'Neill, R. E., J. Talon, and P. Palese. 1998. The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins. EMBO J. 17:288-296.
33. Pinheiro, J. C., and D. M. Bates. 2000. Mixed-effects model in S and S-PLUS. Springer, New York, N.Y.
34. Qiu, Y., and R. M. Krug. 1994. The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A). J. Virol. 68:2425-2432.
35. Qiu, Y., M. Nemeroff, and R. M. Krug. 1995. The influenza virus NS1 protein binds to a specific region in human U6 snRNA and inhibits U6-U2 and U6-U4 snRNA interactions during splicing. RNA 1:304-316.
36. Robertson, J. S., C. W. Naeve, R. G. Webster, J. S. Bootman, R. Newman, and G. C. Schild. 1985. Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs. Virology 143:166-174.
37. Romanova, J., D. Katinger, B. Ferko, R. Voglauer, L. Mochalova, N. Bovin, W. Lim, H. Katinger, and A. Egorov. 2003. Distinct host range of influenza H3N2 virus isolates in Vero and MDCK cells is determined by cell specific glycosylation pattern. Virology 307:90-97.
38. Salvatore, M., C. F. Basler, J. P. Parisien, C. M. Horvath, S. Bourmakina, H. Zheng, T. Muster, P. Palese, and A. Garcia-Sastre. 2002. Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis. J. Virol. 76:1206-1212.
39. Schickli, J. H., A. Flandorfer, T. Nakaya, L. Martinez-Sobrido, A. Garcia-Sastre, and P. Palese. 2001. Plasmid-only rescue of influenza A virus vaccine candidates. Philos. Trans. R. Soc. Lond. B 356:1965-1973.
40. Schild, G. C., J. S. Oxford, J. C. de Jong, and R. G. Webster. 1983. Evidence for host-cell selection of influenza virus antigenic variants. Nature 303:706-709.
41. Scholtissek, C., H. Burger, O. Kistner, and K. F. Shortridge. 1985. The nucleoprotein as a possible major factor in determining host specificity of influenza H3N2 viruses. Virology 147:287-294.
42. Seo, S. H., E. Hoffmann, and R. G. Webster. 2002. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat. Med. 8:950-954.
43. Snyder, M. H., W. T. London, H. F. Maassab, R. M. Chanock, and B. R. Murphy. 1990. A 36 nucleotide deletion mutation in the coding region of the NS1 gene of an influenza A virus RNA segment 8 specifies a temperature-dependent host range phenotype. Virus Res. 15:69-83.
44. Stohr, K. 2003. The global agenda on influenza surveillance and control. Vaccine 21:1744-1748.
45. Subbarao, K., H. Chen, D. Swayne, L. Mingay, E. Fodor, G. Brownlee, X. Xu, X. Lu, J. Katz, N. Cox, and Y. Matsuoka. 2003. Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. Virology 305:192-200.
46. Tian, S. F., A. J. Buckler-White, W. T. London, L. J. Reck, R. M. Chanock, and B. R. Murphy. 1985. Nucleoprotein and membrane protein genes are associated with restriction of replication of influenza A/Mallard/N.Y./78 virus and its reassortants in squirrel monkey respiratory tract. J. Virol. 53:771-775.
47. Wang, W., and R. M. Krug. 1998. U6atac snRNA, the highly divergent counterpart of U6 snRNA, is the specific target that mediates inhibition of AT-AC splicing by the influenza virus NS1 protein. RNA 4:55-64.
48. Wolff, T., R. E. O'Neill, and P. Palese. 1998. NS1-binding protein (NS1-BP): a novel human protein that interacts with the influenza A virus nonstructural NS1 protein is relocalized in the nuclei of infected cells. J. Virol. 72:7170-7180.
49. Wood, J. M., and M. S. Williams. 1998. History of inactivated influenza vaccines, p. 317-323. In K. G. Nicholson, R. G. Webster, and A. J. Hay (ed.), Textbook of influenza. Blackwell Science Ltd., Oxford, United Kingdom.